Status:
COMPLETED
Interest of Lidocaine in Children with Upper Airway Infection Undergoing General Anesthesia
Lead Sponsor:
Tunis University
Conditions:
Upper Respiratory Tract Infections
Perioperative Respiratory Complications
Eligibility:
All Genders
12-14 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to determine whether intravenous (IV) lidocaine reduces the incidence of perioperative respiratory complications (PRCs) in children with upper respiratory tract infe...
Eligibility Criteria
Inclusion
- Children aged 1 to 14 years.
- American Society of Anesthesiologists (ASA) Physical Status Classification I, II, or III.
- Scheduled or urgent surgery or radiological exploration under general anesthesia.
- Upper respiratory tract infection (URTI) symptoms present for less than 15 days.
Exclusion
- Refusal of participation by parents.
- Children on long-term corticosteroid or bronchodilator therapy.
- Contraindications to the use of lidocaine or other drugs used in the protocol.
- Patients who did not adhere to the study protocol.
Key Trial Info
Start Date :
January 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 5 2024
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06584461
Start Date
January 2 2023
End Date
February 5 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bechir Hamza Children's Hospital
Tunis, Tunisia, 1029